NOD2 maybe a biomarker for the survival of kidney cancer patients.

ABSTRACT:

Background

Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) may play an important role in the outcome of kidney cancer patients. To explore the relationship between NOD2 and the prognosis of kidney cancer patients, a databank-based reanalysis was conducted.

Materials and methods

Data related to kidney cancer patients at least with survival information, was obtained mainly from The Cancer Genome Atlas (TCGA). Some clinical data, not available online, was collected by personal email to the author. Then, we reanalyzed all the data in order to make a conclusion about the relationship between NOD2 gene and the prognosis of kidney cancer patients.

Results

A total of 1953 samples with NOD2 information from four databanks of The Cancer Genome Atlas (TCGA)

SUBMITTER: Xu D 

PROVIDER: S-EPMC5731890 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature